2026-01-13 - Analysis Report
**English Report**
================

**Company Overview**
------------------
The UnitedHealth Group Inc (UNH) is a multinational health insurance company.

**Performance Analysis**
-----------------------

### Comparison with S&P 500 (VOO)

* **Cumulative Return**: -19.27% (UNH) vs. 94.34% (VOO)
* **Divergence**: -112.50 (current), max: 29.80, min: -124.60, relative divergence: 7.80%

### Alpha, Beta Analysis Table

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|-------|
| 2016-2018  | 22.0% | 18.6% | 19.0% | 0.9   | 225.7B  |
| 2017-2019  | 27.0% | 18.6% | 10.0% | 0.9   | 266.3B  |
| 2018-2020  | -41.0% | 32.5% | -62.0% | 1.1   | 317.7B  |
| 2019-2021  | 16.0% | 32.5% | -27.0% | 1.1   | 454.9B  |
| 2020-2022  | 0.0%  | 31.5% | 2.0%  | 0.9   | 480.3B  |
| 2021-2023  | 23.0% | 13.4% | 23.0% | 0.5   | 476.9B  |
| 2022-2024  | -24.0% | 23.1% | -44.0% | 0.4   | 458.2B  |
| 2023-2025  | -55.0% | 58.5% | -118.0% | 0.3   | 299.0B  |

### Recent Stock Price Fluctuations Table

| Figure      |
|-------------|
| Close       | $340.51     |
| Last-market | {'price': 340.51, 'previousClose': 343.98, 'change': -1.01} |
| 5-day SMA   | $344.40     |
| 20-day SMA  | $335.27     |
| 60-day SMA  | $335.54     |

### RSI, PPO, and Other Analysis

* **RSI**: 61.81
* **PPO**: 0.40
* **Market Risk Indicator (MRI)**: 0.80
* **Relative Divergence Change**: -0.90 (-): worsening
* **7-day Rank change**: -3 (-): rank down
* **7-day Dynamic Expected Return change**: -38.60 (-): worsening
* **Expected Return**: -274.70%

### Recent News & Significant Events

Multiple news articles are listed, indicating recent scrutiny and controversy surrounding the company's Medicare tactics.

### Analyst Opinions

* **Analyst Consensus**: Buy
* **Mean**: 1.93 (~Buy)
* **Opinions**: 26
* **Target Price**: 393.85 / 444.00 / 280.00

### Recent Earnings Analysis Table

| Date | EPS | Revenue |
|------|-----|---------|
| 2025-10-28 | 2.59 | 113.16B$ |
| 2025-08-11 | 3.76 | 111.62B$ |
| 2025-05-07 | 6.9  | 109.58B$ |
| 2024-11-04 | 6.56 | 100.82B$ |
| 2025-10-28 | 6.56 | 100.82B$ |

### Financial Information

#### Revenue and Profitability Table

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24%        |
| 2025-06-30 | $111.62B | 17.93%        |
| 2025-03-31 | $109.58B | 21.70%        |
| 2024-12-31 | $100.81B | 21.14%        |
| 2024-09-30 | $100.82B | 22.84%        |

#### Capital and Profitability Table

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

**Comprehensive Analysis (Summary)**
--------------------------------

The UnitedHealth Group Inc (UNH) has experienced a cumulative return of -19.27% compared to 94.34% for the S&P 500 (VOO). The company's Alpha and Beta values indicate medium to low investment risk. The recent news articles highlight controversy surrounding the company's Medicare tactics, which may impact future performance.

The analysts' consensus is Buy, with a mean rating of 1.93 and a target price range of 393.85-444.00 per share. The company's recent earnings analysis shows mixed results, with increasing revenue and profit margins in some quarters.

Considering these factors, the expected return is -274.70%, and the market risk indicator is 0.80, indicating a medium investment risk.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.